Session 15: Decision-Making, AI and ART
Hosts Alison Campbell & Charlene Alouf
Non-Invasive Embryo selection through Deep learning AI and Time-lapse imaging
Daniella Gilboa
AI Technology to Improve Embryo Selection using Still Images
Dr. Michelle Perugini
Using Artificial Intelligence to Assess Egg Quality - Innovative Technology and Clinical Applications
Dr. Dan Nayot
Daniella Gilboa
Daniella Gilboa, CEO and Cofounder of AiVF, is an embryologist, biostatistician, entrepreneur and an IVF researcher. Her vast experience in embryology led her to co-found AiVF. AiVF develops a data and AI driven comprehensive platform for IVF treatment process. Through Daniella’s notoriety in the IVF industry, AiVF is collaborating with international well-known institutions. Prior to AiVF Daniella worked as a Senior Biostatistician and as a senior embryologist. Daniella speaks worldwide on IVF in general as well utilizing deep technology in making IVF more effective and accessible.
Dr. Michelle Perugini
Dr. Michelle Perugini is an academic and entrepreneur with extensive experience in health and medical research, and advanced AI technologies. Dr Perugini has a PhD in Medicine and spent over a decade as a stem cell biologist specialising in predictive genetics and translational medicine. In 2007, Dr Perugini Co-Founded a global technology company, ISD Analytics, using AI to predict human behaviour of whole populations to assist with strategic and social policy planning. ISD was acquired by Ernst and Young {EY) in 2015.
Dr Perugini is now the Co-Founder and CEO of Presagen, an AI company that connects clinics globally to build scalable AI medical products. Presagen’s first product is Life Whisperer, a web-based application that uses AI to assist clinicians with embryo selection during the IVF process to improve pregnancy success rates and shorten the time to pregnancy for patients. Life Whisperer is commercially available globally. The company now has a global clinical collaborative project open for its second AI product for non-invasive embryo assessment during IVF.
Dr. Dan Nayot - B.Sc., M.Sc., M.D., FRCSC, REI
Dr. Dan Nayot is a staff physician at TRIO Fertility. He trained at internationally recognized institutions, completing his Obstetrics and Gynecology Residency at the University of Toronto and subsequently his fellowship in Gynecologic Reproductive Endocrinology and Infertility at McGill University.
Continuing his academic pursuits at Harvard University, Dr. Nayot received his Masters of Science degree in Clinical Epidemiology. He has been awarded several research grants and academic scholarships, authored numerous scientific papers, and presented at international medical conferences.
Dr. Nayot is an active reviewer for several esteemed fertility scientific journals and continues to be involved in clinical research, as well as training students at various stages of their medical programs.
His academic pursuits have evolved into the entrepreneurial domain, co-founding several fertility-focused start-ups and actively working as an expert consultant. He is the Co-Founder and Medical Director of Future Fertility; Applying Artificial Intelligence to Reproductive Medicine through image analysis of oocytes, embryos and endometrium. He is also a Co-Founder of Bird and Bee (At home urine based fertility testing) and Halohealth (Canada’s first MD Angel Network for Healthcare Technology).